EGFR
Associated Syndrome
EGFR-associated Cancer Risk
Core Cancer Risk(s)
Non-small cell Lung Cancer
Inheritance
Autosomal Dominant
Prevalence
Unknown
CANCER TYPE
AGE RANGE
CANCER RISK
RISK FOR GENERAL POPULATION
Lung
To age 80
Elevated Risk
4.3%
CANCER TYPE
PROCEDURE
AGE TO BEGIN
FREQUENCY
Lung
Currently there are no specific medical management guidelines for lung cancer risk in mutation carriers. However, the increased risk may warrant consideration of individualized screening with low dose chest CT scans, as has been considered for individuals at increased risk due to smoking.
NA
NA
For Patients with a Cancer Diagnosis
For patients with a diagnosis of lung cancer, the presence of this EGFR gene mutation may impact decisions about the choice of drugs for therapy.
NA
NA